- Home
- SAIA vs RGC Comparison
SAIA vs RGC Comparison
Compare SAIA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SAIA | RGC |
|---|---|---|
| Founded | 1924 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.8B |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SAIA | RGC |
|---|---|---|
| Price | $337.06 | $20.92 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $349.53 | N/A |
| AVG Volume (30 Days) | ★ 438.4K | 325.8K |
| Earning Date | 02-10-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.58 | N/A |
| Revenue | ★ $3,233,286,000.00 | N/A |
| Revenue This Year | $2.33 | N/A |
| Revenue Next Year | $5.09 | N/A |
| P/E Ratio | $31.86 | ★ N/A |
| Revenue Growth | ★ 1.96 | N/A |
| 52 Week Low | $229.12 | $0.09 |
| 52 Week High | $538.03 | $83.60 |
Technical Indicators
Market Signals| Indicator | SAIA | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 57.60 |
| Support Level | $324.87 | $19.80 |
| Resistance Level | $334.40 | $25.50 |
| Average True Range (ATR) | 9.87 | 2.71 |
| MACD | -1.68 | 0.13 |
| Stochastic Oscillator | 60.77 | 47.37 |
Price Performance
Historical ComparisonAbout SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.